drugset / Trial / NCT01725646

An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients

NCT01725646

Phase 3 Completed 253 enrolled Excelsior
RandomizedParallel-groupQuadruple-blindTreatment

Summary

1. Evaluation of the efficacy of Omacor® in Taiwanese hypertriglyceridemia patients 2. Evaluation of the safety of Omacor® in Taiwanese hypertriglyceridemia patients

Timeline

Start
2011-07
Primary completion
2013-07
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lovaza Other / unclassified 2 g
Comparator Lovaza Other / unclassified 4 g

Indications